Thermo King is partnering with Mercedes-Benz AG to create a fully electric, refrigerated Mercedes-Benz eSprinter van for final mile delivery of pharmaceuticals and medicines.
The prototype comes with the all-electric E-200 refrigeration unit and the new lithium-ion (Li-ion) battery from Thermo King.
The combination delivers independent and constant capacity ensuring an unbroken cold chain even during driver breaks, which ensures the quality of transported pharmaceuticals and medicines.
Eneko Fernandez, product management leader at Thermo King said: “The collaboration between Thermo King and Mercedes-Benz AG to develop an all-electric pharma- delivery vehicle will enable our customers to benefit from the best combination of distribution and refrigeration technologies.
“Electrification of transport industry is a trend that addresses the noise and emission pollution in cities and urban areas. At Thermo King, we want to challenge what is possible in our industry.
“Working together with Mercedes-Benz Vans on the eSprinter Pharma, we are developing a local zero-emission refrigerated transportation that will help improve the quality of life, in a sustainable way.”
Matthias Brzenczek, industry manager for Pharma at Mercedes-Benz AG added: “Sustainability and environmental protection are increasingly important for our customers, who are facing more and more challenges that apply to inner city deliveries.
“With the eSprinter Pharma, we want to offer a sustainable, electrically-powered van specifically built to meet the needs of the pharmaceutical industry.
“From the outset, we wanted to avoid solutions using independent auxiliary battery or passive cooling methods. We want our customers to be able to rely on an active and efficient cooling and heating system in the load compartment.”
The prototype van has undergone its initial rounds of successful testing. Over a period of four weeks, the vehicle drove more than 2,000km maintaining the temperature of the load compartment between 15 and 25 degrees Celsius, and successfully delivering pharmaceuticals to pharmacies in and around the city. Further testings are planned for the end of 2020 and early 2021.
